Abstract
This article is a position paper of the Canadian College of Neuropsychopharmacology (CCNP). It was approved unanimously at a meeting of the CCNP Council on June 2, 1996, and at the CCNP Annual General Business Meeting on June 4, 1996.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown W. A. Placebo as a treatment for depression. Neuropsychopharmacology. 1994 Jul;10(4):265–288. doi: 10.1038/npp.1994.53. [DOI] [PubMed] [Google Scholar]
- Davis J. M., Wang Z., Janicak P. G. A quantitative analysis of clinical drug trials for the treatment of affective disorders. Psychopharmacol Bull. 1993;29(2):175–181. [PubMed] [Google Scholar]
- Ernst E., Resch K. L. Concept of true and perceived placebo effects. BMJ. 1995 Aug 26;311(7004):551–553. doi: 10.1136/bmj.311.7004.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisher S., Greenberg R. P. How sound is the double-blind design for evaluating psychotropic drugs? J Nerv Ment Dis. 1993 Jun;181(6):345–350. doi: 10.1097/00005053-199306000-00002. [DOI] [PubMed] [Google Scholar]
- Greenberg R. P., Bornstein R. F., Greenberg M. D., Fisher S. A meta-analysis of antidepressant outcome under "blinder" conditions. J Consult Clin Psychol. 1992 Oct;60(5):664–677. doi: 10.1037//0022-006x.60.5.664. [DOI] [PubMed] [Google Scholar]
- Klerman G. L. Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology. Psychopharmacol Bull. 1986;22(1):25–29. [PubMed] [Google Scholar]
- Leber P. Is there an alternative to the randomized controlled trial? Psychopharmacol Bull. 1991;27(1):3–8. [PubMed] [Google Scholar]
- Rickels K. Use of placebo in clinical trials. Psychopharmacol Bull. 1986;22(1):19–24. [PubMed] [Google Scholar]
- Thomson R. Side effects and placebo amplification. Br J Psychiatry. 1982 Jan;140:64–68. doi: 10.1192/bjp.140.1.64. [DOI] [PubMed] [Google Scholar]